Primary Record
Ripretinib
- In stock
- 871 g
- Purity
- 98.7 %
- CAS
- 1442472-39-0
Compound Identifiers & Properties
- CAS
- 1442472-39-0
- PubChem CID
- 71584930
- SMILES
- CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC
- Canonical SMILES
- CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21
Names & Synonyms
- Ripretinib
- qinlock
- ripretinibum
- DCC-2618
- Quinlock
- gluconate sodium
- Ripretinib free base
- 1442472-39-0
- Ripretinib [USAN]
- Qinlock (TN)
- Ripretinib (USAN)
- Ripretinib (DCC-2618)
- RefChem:57787
- RIPRETINIB [MI]
- RIPRETINIB [INN]
- C24H21BrFN5O2
- DCC2618
- 9XW757O13D
- RIPRETINIB [WHO-DD]
- Ripretinib (DCC-2618)?
- UNII-9XW757O13D
- DTXSID201027956
- GTPL9175
- orb1298897
- CHEMBL4216467
- RIPRETINIB [ORANGE BOOK]
- SCHEMBL14999718
- SCHEMBL29362351
- MFCD31657437
- DTXCID101513524
- GLXC-15506
- HMS5086E13
- 1442472-39-0 (free base)
- KIT/PDGFR Inhibitor DCC-2618
- BCP29218
- EX-A4883
- BDBM50609506
- EBC-27255
- s8757
- AKOS040759418
- AT18473
- DB14840
- AC-36722
- BP-44046
- CID:71584930
- DA-52358
- MS-29471
- SID:482324347
- HY-112306
- CS-0044835
- J3.755.366B
- D11353
- 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
- A999840
- EN300-22895298
- DCC 2618;DCC2618;KIT/PDGFR inhibitor;Ripretinib
- C000707850
- Urea, N-(4-bromo-5-(1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-N'-phenyl-
- B0084-457687
- B2693-291572
- N-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-N'-phenylurea
- 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
- 1225278-16-9
- 3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea
- 3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea
- 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
- 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluoro-phenyl]-3-phenyl-urea
- 1-N'-(2,5-difluoro-4-(2-(1-methylpyrazol-4-yl)pyridin-4-yl)oxyphenyl)-1-N'-phenylcyclopropane-1,1-dicarboxamide
- N-[4-Bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-N'-phenylurea
- Ripretinib; Urea, N-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-N'-phenyl-; N-[4-Bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-N'-phenylurea; 1-[4-Bromo-5-[1-ethyl-7-(methyla